Nebulized Albuterol Will Not Get NCD Due To Lack Of Data On Patient Subgroups, But Xopenex Loses On Payment Side

Medicare Part B coverage policy for nebulized beta adrenergic agonist therapy for lung disease will continue to be the purview of local Medicare claims contractors.